ClinConnect ClinConnect Logo
Search / Trial NCT07041229

Comparison of Methods for Removing Large Benign Broad-based Epithelial Neoplasms of the Colon: ESD and EMR.

Launched by PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY · Jun 19, 2025

Trial Information

Current as of June 30, 2025

Enrolling by invitation

Keywords

Esd, Emr

ClinConnect Summary

Objective of the study: to prospectively compare the immediate, immediate and remote results of endoscopic mucosal resection through an endoscope and endoscopic submucosal dissection performed for non-invasive large-sized (20 mm or more) broad-based epithelial lesions of the colon.

Study objectives:

1. To evaluate the accuracy of ultra-high-resolution colonoscopy in white, ultra-clear and narrow-spectrum light with magnification in predicting the histological structure and risks of invasion of large-sized broad-based epithelial lesions of the colon.
2. To conduct a comparative assessment ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with benign non-invasive epithelial formations of the colon on a broad base (Is and II types), 20-60 mm in size
  • Age ≥ 18 years.
  • Signed informed voluntary consent for colonoscopy and removal of formations using the studied methods of EMR and ESD
  • Exclusion Criteria:
  • . More than one large epithelial lesion on a broad base
  • Colon lesion less than 20 mm and more than 60 mm
  • Recurrent lesion.
  • Reasonable suspicion of an invasive lesion (cancer), including one with submucosal invasion based on the results of preoperative assessment (NICE - 3; JNET - 3; Kudo - Vn).
  • Presence of widespread malignant tumour in any part of the colon.
  • Use of other methods of endoscopic lesion removal.
  • IBD.
  • Infectious disease requiring systemic therapy
  • Patient on haemodialysis
  • Uncorrectable coagulopathy (INR\> 1.5), inability to discontinue antithrombotic drugs.
  • Refusal to participate in the study. 12. General contraindications to endoscopic examination.

About Pirogov Russian National Research Medical University

Pirogov Russian National Research Medical University is a prestigious academic institution dedicated to advancing medical science and education in Russia. Renowned for its commitment to high-quality research and innovation, the university plays a pivotal role in clinical trials aimed at improving healthcare outcomes. With a multidisciplinary approach, it fosters collaboration among leading experts in various medical fields, ensuring the development of safe and effective therapeutic interventions. The institution is focused on translating research findings into clinical practice, thereby contributing significantly to the advancement of medical knowledge and patient care both nationally and internationally.

Locations

Moscow, , Russian Federation

Patients applied

0 patients applied

Trial Officials

Evgeny Gorbachev

Study Chair

Pirogov Russian National Research Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported